May 1, 2012
ViroPharma Incorporated Reports First Quarter 2012 Financial Results
Apr 10, 2012
ViroPharma Provides Update on Status of Citizen Petition Regarding Bioequivalence and Exclusivity for Vancocin® (vancomycin hydrochloride, USP) Capsules
Mar 29, 2012
ViroPharma Launches Hereditary Angioedema Facebook App to Encourage Education and Diagnosis of Hereditary Angioedema Through Discussion of Family History
Mar 6, 2012
ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20)
Feb 28, 2012
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
Feb 16, 2012
Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism
Feb 15, 2012
ViroPharma to Release 2011 Fourth Quarter and Full Year Financial Results on February 28, 2012
Feb 14, 2012
ViroPharma to Participate in Two Upcoming Healthcare Investor Conferences
Feb 7, 2012
ViroPharma Provides Update on Industrial Scale Supplement for Cinryze® (C1 Esterase Inhibitor [Human])
Jan 13, 2012
Health Canada Grants Priority Review Status For New Drug Submission (NDS) For Cinryze™ (C1 Inhibitor [human])
Jan 5, 2012
ViroPharma Provides 2012 Outlook
Jan 3, 2012
ViroPharma Announces Appointment of Julie H. McHugh to Board of Directors
Dec 22, 2011
ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma
Dec 14, 2011
ViroPharma Announces Approval of Modernized Labeling for Vancocin® (vancomycin hydrochloride, USP) Capsules
Dec 6, 2011
ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
Dec 5, 2011
ViroPharma to Participate in Two December Healthcare Investor Conferences
Nov 15, 2011
ViroPharma Completes Acquisition of DuoCort Pharma AB
Nov 7, 2011
DuoCort Pharma's Orphan Drug Plenadren® Granted European Marketing Authorization for Adrenal Insufficiency
Nov 2, 2011
ViroPharma to Participate in Two November Healthcare Investor Conferences
Oct 27, 2011
ViroPharma Incorporated Reports Third Quarter 2011 Financial Results
Oct 27, 2011
ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline
Oct 19, 2011
ViroPharma to Release 2011 Third Quarter Financial Results on October 27, 2011
Sep 30, 2011
ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreich's Ataxia
Sep 15, 2011
ViroPharma Expands Its Innovative "HAE and Me" Online Community With Education and Support to Meet Unique Needs of Hereditary Angioedema Caregivers
Sep 15, 2011
ViroPharma Announces Additional Securities Repurchase Program
Sep 11, 2011
ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
Sep 6, 2011
ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
Aug 31, 2011
ViroPharma to Participate in the Stifel Nicolaus 2011 Healthcare Conference
Jul 28, 2011
ViroPharma Incorporated Reports Second Quarter 2011 Financial Results
Jul 21, 2011
ViroPharma to Release 2011 Second Quarter Financial Results on July 28, 2011
Jun 24, 2011
ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
Jun 15, 2011
ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
Jun 13, 2011
Nine Abstracts Relating to Cinryze® (C1 Esterase Inhibitor [human]) Data Presented at 30th Congress of the European Academy of Allergy and Clinical Immunology (EAACI)
May 26, 2011
ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
May 19, 2011
ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
May 11, 2011
ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
Apr 28, 2011
ViroPharma Incorporated Reports First Quarter 2011 Financial Results
Apr 27, 2011
ViroPharma to Participate In Three May Healthcare Investor Conferences
Apr 20, 2011
ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
Mar 29, 2011
ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of AntibodyMediated Rejection (AMR)
Mar 22, 2011
Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting
Mar 21, 2011
ViroPharma Launches 'HAE and Me,' A New Online Community to Unite People Living With Hereditary Angioedema
Mar 18, 2011
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Mar 9, 2011
ViroPharma Announces Securities Repurchase Program
Feb 28, 2011
ViroPharma to Participate in Two March Healthcare Conferences
Feb 24, 2011
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2010 Financial Results
Feb 11, 2011
ViroPharma to Participate in the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
Feb 10, 2011
ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
Jan 10, 2011
ViroPharma Provides 2011 Outlook
Jan 5, 2011
ViroPharma to Participate in the 29th Annual J.P. Morgan Healthcare Conference
Dec 6, 2010
ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program
Dec 6, 2010
Cinryze(R) (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
Nov 24, 2010
ViroPharma to Participate in Two December Healthcare Investor Conferences
Nov 15, 2010
Cinryze(R) (C1 esterase inhibitor [human]) Data Presented at 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
Nov 9, 2010
ViroPharma Announces Six Upcoming Presentations of Cinryze(TM) (C1 Esterase Inhibitor (Human)) Data at 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
Oct 29, 2010
ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences
Oct 27, 2010
ViroPharma Incorporated Reports Third Quarter 2010 Financial Results
Oct 25, 2010
ViroPharma Announces Completion of Enrollment in Phase 2 Study Evaluating Subcutaneous Delivery of Cinryze(TM) (C1 Esterase Inhibitor [Human])
Oct 22, 2010
ViroPharma Receives Complete Response Letter for Cinryze(TM) (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
Oct 20, 2010
ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010
Sep 29, 2010
ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
Sep 15, 2010
ViroPharma Announces Presentation of Data from NonToxigenic Clostridium difficile (VP20621) Phase 1 Study
Sep 7, 2010
ViroPharma To Participate in Two September Healthcare Investor Conferences
Aug 5, 2010
ViroPharma Announces Publication of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine